New tests launched in May and June
In May and June 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
The new tests that launched in May and June 2021 by Mayo Clinic Laboratories:
APOL1 | APOL1 Genotype, Varies
This test is useful for determining an individual’s APOL1 genotype.
This test is useful for diagnosing mesothelioma by detecting a neoplastic clone associated with deletion involving the CDKN2A gene region at 9p21
This test is useful for evaluating patients with paraneoplastic or autoimmune encephalitis (brainstem encephalitis or limbic encephalitis or cerebellar ataxia) using spinal fluid specimens